Business Wire
AstraZeneca and Joshua Jackson partner to encourage fans to Get Body Checked Against Cancer
📊
AI Sentiment
Positive
7/10
AstraZeneca PLC News
Latest updates and market news for AZN
20 news
Mar 5 - Mar 11, 2026
Page 1
Simply Wall St.
Is AstraZeneca (LSE:AZN) Still Attractive After Recent Share Price Pullback?
📈
AI Sentiment
Highly Positive
8/10
Simply Wall St.
AstraZeneca Oncology Updates Prompt Fresh Look At Valuation And Growth Potential
📈
AI Sentiment
Highly Positive
8/10
Reuters
Factbox-Global drugmakers rush to boost US presence as tariff threat looms
📈
AI Sentiment
Highly Positive
9/10
Zacks
Will Weak Gardasil Sales Continue to Weigh on MRK's Top Line in 2026?
📉
AI Sentiment
Negative
2/10
CNW Group
Koselugo approved in Canada for plexiform neurofibromas in adults with neurofibromatosis type 1
📈
AI Sentiment
Highly Positive
9/10
Argus Research
Daily Spotlight: A Range of Options Among Sovereign Debt
âž–
AI Sentiment
Neutral
4/10
Business Wire
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer
📈
AI Sentiment
Highly Positive
10/10
MT Newswires
AstraZeneca, Daiichi Sankyo Wins Priority Review for Enhertu for Breast Cancer
âž–
AI Sentiment
Neutral
5/10
Simply Wall St.
Assessing AstraZeneca (LSE:AZN) Valuation After Recent Share Price Weakness
📊
AI Sentiment
Positive
6/10
Zacks
Will Linzess Continue to Aid IRWD's Top Line in 2026 After a Soft Q4?
📊
AI Sentiment
Positive
7/10
Proactive
Jefferies raises AstraZeneca target to 18,000p as analysts flip view on delayed cancer trial
📈
AI Sentiment
Highly Positive
8/10
Zacks
The Zacks Analyst Blog Highlights Exxon Mobil, Palantir, AstraZeneca, Gencor Industries and Hour Loop
📊
AI Sentiment
Positive
7/10
Zacks
Top Analyst Reports for Exxon Mobil, Palantir & AstraZeneca
📈
AI Sentiment
Highly Positive
8/10
PR Newswire
Third Annual Bio-IT World Venture, Innovation & Partnering Conference Returns to Boston May 19
📈
AI Sentiment
Highly Positive
8/10
Zacks
Can Pfizer Reignite Growth Amid COVID Declines and Patent Expirations?
📉
AI Sentiment
Negative
3/10
Share this news page